Epidemiology and Pathophysiology of Prostate Cancer in African-American Men
Abstract
Purpose:
Along with increasing age and a positive family history subSaharan African ancestry has long been recognized as an important risk factor for prostate cancer. In the United States the incidence of prostate cancer is approximately 60% higher in African-American than in European-American men and the mortality rate from the disease is more than twice as high. The purpose of this review article is to examine specific reports highlighting racial disparity and its possible causes.
Materials and Methods:
The reports chosen for review of this epidemiology and pathophysiology study were included to demonstrate conditions in which racial differences as well as similarities exist in African-American and European-American men. Reports also include autopsy, biological and clinical studies, and early and late stage prostate cancer.
Results:
From the 1970s to the current statistical analysis of the National Cancer Institute Surveillance, Epidemiology, and End Results program African-American men have continued to have a significant higher incidence and mortality rate than European-American men. Autopsy studies show a similar prevalence of early small subclinical prostate cancers but a higher prevalence of high grade prostatic intraepithelial neoplasia. Clinical studies show a similarity in prostate cancer outcome when pathological stage is organ confined but a worse outcome when disease is locally advanced and metastatic in African-American vs European-American men. There is increasing genetic evidence that suggest that prostate cancer in African-American vs European-American men may be more aggressive, especially in young men.
Conclusions:
Improving the outcome in African-American men with prostate cancer requires awareness of the epidemiological patterns of the disease and willingness on the part of physicians to implement targeted study initiatives with end points designed to detect the disease early in this population and begin appropriate management. It is proposed that a multi-institutional study should be done to demonstrate the ability to decrease racial outcome disparity by education, aggressive testing and treatment.
References
- 1 : Cancer facts and figures 2004. : 2004. Available at http://www.cancer.org/docroot/STT/stt_0.asp. Accessed August 6. Google Scholar
- 2 : Epidemiology of prostate cancer. Urology2003; 62: 3. Google Scholar
- 3 : Prostate cancer epidemiology. Lancet2003; 361: 859. Google Scholar
- 4 : Epidemiology of prostate cancer. CA Cancer J Clin1997; 47: 273. Google Scholar
- 5 : The complex genetic epidemiology of prostate cancer. Hum Mol Genet, suppl.2004; 13: R103. Google Scholar
- 6 : Prostate cancer and black men. Semin Urol Oncol1998; 16: 184. Google Scholar
- 7 : Cancer facts and figures for AAMs 2003-2004. : 2004. Available at http://www.cancer.org/docroot/STT/stt_0.asp. Accessed March 24. Google Scholar
- 8 : Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst2001; 93: 705. Google Scholar
- 9 : A successful recruitment process of African American men for early detection of prostate cancer. Cancer1995; 75: 1880. Google Scholar
- 10 : Differences in socioeconomic status and survival among white and black men with prostate cancer. Am J Epidemiol2000; 151: 409. Google Scholar
- 11 : CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy. J Urol2004; 172: 1848. Link, Google Scholar
- 12 : Racial differences in androgen receptor protein expression in men with clinically localized prostate cancer. J Urol2003; 170: 990. Link, Google Scholar
- 13 : Recent developments in the epidemiology of prostate cancer. Eur J Cancer1997; 33: 340. Google Scholar
- 14 : The epidemiology of prostate cancer in the United States. Semin Oncol Nurs2001; 17: 72. Google Scholar
- 15 Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L et al: SEER Cancer Statistics Review, 1975–2002, National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/1975_2002/. Accessed September 2005. Google Scholar
- 16 : The epidemiology of prostate cancer in Jamaica. J Urol1998; 159: 1984. Link, Google Scholar
- 17 : Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int J Cancer2001; 96: 363. Google Scholar
- 18 : Trends in prostate cancer mortality among black men and white men in the United States. Cancer2003; 97: 1507. Google Scholar
- 19 : Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst2001; 93: 219. Crossref, Medline, Google Scholar
- 20 : The frequency of carcinoma and intraepithelial neoplasm of the prostate in young male patients. J Urol1993; 150: 379. Link, Google Scholar
- 21 : Age and racial distribution of prostate intraepithelial neoplasia. Eur Urol1996; 30: 138. Google Scholar
- 22 : Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of black and white Americans. J Urol2005; 174: 872. Google Scholar
- 23 : Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA1995; 274: 1277. Crossref, Medline, Google Scholar
- 24 : Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study. J Natl Cancer Inst2001; 93: 388. Google Scholar
- 25 : Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients. J Urol1999; 162: 394. Link, Google Scholar
- 26 : Black-white differences in the stage at presentation of prostate cancer in the District of Columbia. Urology1995; 46: 71. Crossref, Medline, Google Scholar
- 27 : Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst2002; 94: 334. Google Scholar
- 28 : Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst2001; 93: 1864. Google Scholar
- 29 : Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States). Cancer Causes Control1999; 10: 503. Google Scholar
- 30 : Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care1998; 36: 1337. Google Scholar
- 31 : Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol2004; 171: 1504. Link, Google Scholar
- 32 : Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. Gen Intern Med2004; 19: 146. Google Scholar
- 33 : Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA1995; 274: 1599. Crossref, Medline, Google Scholar
- 34 : Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery2002; 132: 213. Google Scholar
- 35 : Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival?: A comparative study between black and white men in a Veterans Affairs system. Urology1995; 46: 825. Google Scholar
- 36 : Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol1996; 155: 1667. Link, Google Scholar
- 37 : Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males. Cancer1998; 83: 2353. Google Scholar
- 38 : Disease-free survival difference between African-Americans and whites after radical prostatectomy for local prostate cancer: a multivariable analysis. Urology2002; 59: 907. Google Scholar
- 39 : Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?. J Urol2002; 168: 2510. Link, Google Scholar
- 40 : The effect of race/ethnicity on prostate cancer treatment outcome is conditional: a review of Wayne State University data. J Urol2004; 171: 1508. Link, Google Scholar
- 41 : Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst1986; 76: 45. Google Scholar
- 42 : Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids1992; 57: 72. Google Scholar
- 43 : Impact of CAG repeats in exon 1 of the androgen receptor on disease progression after prostatectomy. Cancer2005; 103: 528. Google Scholar
- 44 : Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4. J Natl Cancer Inst1998; 90: 1225. Google Scholar
- 45 : A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history. J Med Genet2006; 43: 5067. Google Scholar
- 46 : Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev2003; 12: 120. Google Scholar
- 47 : Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. Urol Oncol2006; 24: 21. Google Scholar
- 48 : Racial differences in clinically localized prostate cancers of black and white men. J Urol1998; 159: 1979. Link, Google Scholar
- 49 : Certain aspects of molecular endocrinology that relate to the influence of dietary factors on the pathogenesis of prostate cancer. Eur Urol1999; 35: 443. Google Scholar
- 50 : Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst1995; 87: 652. Google Scholar
- 51 : Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy. J Clin Oncol2004; 22: 439. Google Scholar
Department of Urology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan
